BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT03384654-completion@plaintrial.com
DTSTAMP:20261028T002148Z
DTSTART;VALUE=DATE:20220927
SUMMARY:A Study to Evaluate the Efficacy and Safety of Daratumumab in Pedia
 tric and Young Adult Participants Greater Than or Equal to (>=)1 and Less 
 Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B
 -cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma —
  estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT03384654
URL:https://plaintrial.com/trial/NCT03384654
END:VEVENT
END:VCALENDAR